Convenient, physician-guided medical insights help people manage health without a trip to the doctor's office More than 50 tests available (at home & patient service center collection options) for ...

Though countless diagnostic developers struck it rich at the height of the COVID-19 pandemic, many of those that were relatively new to the testmaking game are now struggling to make up for lost sales ...

Starting today, people in the US can order the tests on Quest's consumer testing site without visiting a doctor. At $119, the kit is one of the more expensive offered on Quest's site. It requires a ...

In addition, under a separate, previously announced laboratory services agreement, Quest later this month will begin to provide comprehensive dialysis-related laboratory services for dialysis centers ...

With the most comprehensive Epic integration by a laboratory provider, collaboration will streamline and strengthen the customer experience for health systems, hospitals, independent providers and ...

Quest Diagnostics unveiled a first-to-market blood test available for consumer purchase that detects and measures the level of per- and polyfluorinated alkyl substances (PFAS), a potentially harmful ...

Quest Diagnostics will take over the kidney-focused lab testing portfolio of the dialysis giant Fresenius Medical Care—including services that Quest will then provide back to Fresenius as well as its ...

Quest Diagnostics Incorporated DGX recently entered into a collaboration with CLX Health to offer access to COVID-19 molecular diagnostic testing (PCR/NAAT) for people looking to attend live events ...

Sometimes, I'm not alone with my thoughts. This TechRepublic Premium ebook compiles the latest on cancelled conferences, cybersecurity attacks, remote work tips, and the impact this pandemic is having ...

SECAUCUS, N.J., July 15, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced the launch of a new diagnostic laboratory test for the ...

Quest Diagnostics has completed its acquisition of select clinical testing assets from Spectra Laboratories, owned by Fresenius Medical Care. The deal positions Quest to provide dialysis-related ...